ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,763Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 546

$620K Total Retail Price of All Prescriptions

Rank: 31 out of 546

643 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 643 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 643 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,052 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LEVOTHYROXINE SODIUM 647 536 1 3
FUROSEMIDE 514 446 2 5
METOPROLOL TARTRATE 473 434 3 6
LISINOPRIL 393 300 4 1
HYDROCODONE-ACETAMINOPHEN 335 260 S3 5 8
WARFARIN SODIUM 330 295 6 13
SIMVASTATIN 326 226 7 2
AMLODIPINE BESYLATE 287 258 8 9
ATORVASTATIN CALCIUM 259 235 9 11
ATENOLOL 258 214 10 12
TRAMADOL HCL 255 188 11 19
METFORMIN HCL 234 140 12 10
HYDROCHLOROTHIAZIDE 231 189 13 7
OMEPRAZOLE 207 138 14 4
PANTOPRAZOLE SODIUM 178 136 15 18
METOPROLOL SUCCINATE 172 157 16 17
DONEPEZIL HCL 163 154 17 31
OXYCODONE HCL 156 53 S2 18 15
FAMOTIDINE 147 127 19 53
SERTRALINE HCL 147 122 19 14
POTASSIUM CHLORIDE 144 128 21 30
SPIRIVA 136 119 22 28
MIRTAZAPINE 134 126 23 51
CITALOPRAM HBR 128 106 24 21
TRAZODONE HCL 127 97 25 25
GABAPENTIN 120 76 26 16
LOSARTAN POTASSIUM 120 101 26 24
POLYETHYLENE GLYCOL 3350 115 93 28 68
PAROXETINE HCL 111 99 29 43
FENTANYL 109 89 S2 30 50
ISOSORBIDE MONONITRATE ER 109 108 30 32
ZOLPIDEM TARTRATE 105 90 32 26
GLIPIZIDE 95 64 33 44
RISPERIDONE 95 79 33 47
RANITIDINE HCL 87 53 35 23
ADVAIR DISKUS 84 57 36 20
LEVETIRACETAM 75 49 37 95
LANTUS 75 53 37 46
CYCLOBENZAPRINE HCL 74 31 R 39 34
LOVASTATIN 73 50 40 22
COMBIVENT 72 65 41 71
DIVALPROEX SODIUM 69 42 42 78
AMITRIPTYLINE HCL 68 44 R 43 48
CRESTOR 64 50 44 36
PROAIR HFA 64 36 44 27
FLUOXETINE HCL 63 33 46 39
VENTOLIN HFA 60 26 47 63
OXYBUTYNIN CHLORIDE ER 58 50 48 105
NITROGLYCERIN PATCH 57 57 49 117
BACLOFEN 56 33 50 86
CARBAMAZEPINE 56 56 50 120
DIGOXIN 54 54 52 62
LACTULOSE 54 28 52 96
PREDNISONE 52 49 54 29
ALLOPURINOL 52 30 54 41
OXYCODONE-ACETAMINOPHEN 51 34 S2 56 54
NEXIUM 50 33 57 52
DILTIAZEM 24HR CD 50 47 57 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.